Arrhythmien bei Lungenerkrankungen

ZUSAMMENFASSUNG

Patienten mit Lungenerkrankungen haben häufig atriale und ventrikuläre Arrhythmien. Die Pathogenese dieser Arrhythmien ist komplex und kann viele Faktoren betreffen. Unter allen Lungenerkrankungen wird besonderes Augenmerk auf den Zusammenhang zwischen Arrhythmien bei Patienten mit COPD und obstruktivem Schlafapnoe-Syndrom gelegt. Dies sind die häufigsten Lungenerkrankungen, von denen angenommen wird, dass sie in Zukunft zunehmen.

• Literatur

• 1 Konecny T, Somers KR, Park JY. et al Chronic obstructive pulmonary disease as a risk factor for ventricular arrhythmias independent of left ventricular function. Heart Rhythm 2018; 15: 832-838
• 2 McCord J, Borzak S. Multifocal atrial tachycardia. Chest 1998; 113: 203-209
• 3 Buch P, Friberg J, Scharling H. et al Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur Respir J 2003; 21: 1012-1016
• 4 Soriano JB, Rigo F, Guerrero D. et al High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest 2010; 137: 333-340
• 5 Cazzola M, Bettoncelli G, Sessa E. et al Prevalence of comorbidities in patients with chronic obstructive pulmonary disease. Respiration 2010; 80: 112-119
• 6 Bhatt SP. Dransfield MT Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res 2013; 162: 237-251
• 7 McCord J, Borzak S. Multifocal Atrial Tachycardia. Chest 1998; 113: 203-209
• 8 Caglar IM, Dasli T, Turhan Caglar FN. et al Evaluation of atrial conduction features with tissue doppler imaging in patients with chronic obstructive pulmonary disease. Clin Res Cardiol 2012; 101: 599-606
• 9 Korantzopoulos P, Kolettis TM, Galaris D. et al The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 2007; 115: 135-143
• 10 Ogi H, Nakano Y, Niida S. et al Is structural remodeling of fibrillated atria the consequence of tissue hypoxia?. Circ J 2010; 74: 1815-1821
• 11 Vestbo J, Hurd SS, Rodriguez-Roisin R. et al An overview of Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (GOLD). Zhonghua yi xue za zhi 2012; 92: 937-938
• 12 Bhatt SP, Dransfield MT. Chronic obstructive pulmonary disease and cardiovascular disease. Transl Res 2013; 162: 237-251
• 13 Terzano C, Romani S, Conti V. et al Atrial fibrillation in the acute, hypercapnic exacerbations of COPD. Eur Rev Med Pharmacol Sci 2014; 18: 2908-2917
• 14 Grabicki M, Parysek H, Batura-Gabryel H. et al Comorbidities as an element of multidimensional prognostic assessment of patients with chronic obstructive pulmonary disease. J Physiol Pharmacol 2008; 59: 297-301
• 15 Roh SY, Choi JI, Lee JY. et al Catheter ablation of atrial fibrillation in patients with chronic lung disease. Circ Arrhythm lectrophysiol 2011; 4: 815-822
• 16 Gu J, Liu X, Tan H. et al Impact of chronic obstructive pulmonary disease on procedural outcomes and quality of life in patients with atrial fibrillation undergoing catheter ablation. J Cardiovasc Electrophysiol 2013; 24: 148-154
• 17 Pisters R, Nieuwlaat R, Prins MH. et al Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012; 14: 666-674
• 18 Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004; 125: 2309-2321
• 19 Huerta C, Lanes SF, García Rodríguez LA. Respiratory medications and the risk of cardiac arrhythmias. Epidemiology 2005; 16: 360-366
• 20 Adeloye D, Chua S, Lee C. et al Global Health Epidemiology Reference Group (GHERG). Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health 2015; 5: 020415
• 21 Wood-Baker R, Cochrane B, Naughton MT. Cardiovascular mortality and morbidity in chronic obstructive pulmonary disease: the impact of bronchodilator treatment. Intern Med J 2010; 40: 94-101
• 22 Kuralay E, Cingöz F, Kiliç S. et al Supraventricular tachyarrythmia prophylaxis after coronary artery surgery in chronic obstructive pulmonary disease patients (early amiodarone prophylaxis trial). Eur J Cardiothorac Surg 2004; 25: 224-230
• 23 Du Q, Sun Y, Ding N. et al Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies. PLOS ONE 2014; 9: e113048
• 24 Gami AS, Olson EJ, Shen WK. et al Obstructive sleep apnea and the risk of sudden cardiac death: a longitudinal study of 10,701 adults. J Am Coll Cardiol 2013; 62: 610-616
• 25 Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52: 490-494
• 26 May AM, Van Wagoner DR, Mehra R. OSA and Cardiac Arrhythmogenesis: Mechanistic Insights. Chest 2017; 151: 225-241
• 27 Baranchuk A. Sleep apnea, cardiac arrhythmias, and conduction disorders. J Electrocardiol 2012; 45: 508-512
• 28 Patel N, Donahue C, Shenoy A. et al Obstructive sleep apnea and arrhythmia: A systemic review. Int J Cardiol 2017; 228: 967-970
• 29 Mehra R, Benjamin EJ, Shahar E. et al Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 2006; 173: 910-916
• 30 Neilan TG, Farhad H, Dodson JA. et al Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc 2013; 2: e000421
• 31 Fein AS, Shvilkin A, Shah D. et al Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013; 62: 300-305
• 32 Naruse Y, Tada H, Satoh M. et al Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm 2013; 10: 331-337
• 33 Qureshi WT, Nasir UB, Alqalyoobi S. et al Meta-analysis of continuous positive airway pressure as a therapy of atrial fibrillation in obstructive sleep apnea. Am J Cardiol 2015; 116: 1767-1773
• 34 Bitter T, Westerheide N, Prinz C. et al Cheyne-Stokes respiration and obstructive sleep apnoea are independent risk factors for malignant ventricular arrhythmias requiring appropriate cardioverter-defibrillator therapies in patients with congestive heart failure. Eur Heart J 2011; 32: 61-74
• 35 Serizawa N, Yumino D, Kajimoto K. et al Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Am J Cardiol 2008; 102: 1064-1068
• 36 Garrigue S, Pépin JL, Defaye P. et al High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation 2007; 115: 1703-1709
• 37 Simantirakis EN, Schiza SI, Marketou ME. et al Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a longterm evaluation using an insertable loop recorder. Eur Heart J 2004; 25: 1070-1076
• 38 van Oosten EM, Furqan MA, Redfearn DP. et al Sleep apnea does not predict atrial flutter recurrence after atrial flutter ablation. J Interv Card Electrophysiol 2012; 34: 73-78